The estimated Net Worth of Peter Cooke is at least $5.12 millió dollars as of 8 November 2018. Mr. Cooke owns over 20,662 units of Wright Medical NV stock worth over $585,479 and over the last 9 years he sold WMGI stock worth over $1,965,543. In addition, he makes $2,572,210 as President, Emerging Markets és Australia and Japan at Wright Medical NV.
Peter has made over 4 trades of the Wright Medical NV stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 20,662 units of WMGI stock worth $604,983 on 8 November 2018.
The largest trade he's ever made was selling 20,662 units of Wright Medical NV stock on 8 November 2018 worth over $604,983. On average, Peter trades about 4,268 units every 0 days since 2015. As of 8 November 2018 he still owns at least 19,529 units of Wright Medical NV stock.
You can see the complete history of Mr. Cooke stock trades at the bottom of the page.
Peter S. Cooke serves as President, Emerging Markets, Australia and Japan of the Company. Prior to such position, he served as President, International from October 2015 to December 2018. He was appointed to that position in connection with the Wright/Tornier merger. Mr. Cooke served as President, International of Wright Medical Group, Inc. from January 2014 to October 2015 and served as Senior Vice President, International from January 2013 to January 2014. Prior to joining legacy Wright, Mr. Cooke served as Vice President and General Manager, Vascular Therapies Emerging Markets of Covidien plc, a global healthcare products company, from July 2010 to January 2013. Prior to Covidien, Mr. Cooke served in various general management roles for ev3 Inc., a global endovascular device company acquired by Covidien in July 2010, including Vice President and General Manager, International from July 2008 to July 2010; Vice President, General Manager, International from November 2006 to June 2008; Vice President, Sales International from January 2005 until November 2006; and Regional Director Asia Pacific and China from February 2003 until January 2005. Prior to ev3, Mr. Cooke spent eleven years at Guidant Corporation, three years at Baxter Healthcare Corporation and two years at St. Jude Medical, Inc.
As the President, Emerging Markets és Australia and Japan of Wright Medical NV, the total compensation of Peter Cooke at Wright Medical NV is $2,572,210. There are 1 executives at Wright Medical NV getting paid more, with Robert Palmisano having the highest compensation of $7,309,180.
Peter Cooke is 55, he's been the President, Emerging Markets és Australia and Japan of Wright Medical NV since 2019. There are 12 older and 10 younger executives at Wright Medical NV. The oldest executive at Wright Medical Group NV is Robert Palmisano, 75, who is the President and Chief Executive Officer, Executive Director.
Peter's mailing address filed with the SEC is 1023, Cherry Road, The Village, Memphis, Shelby County, Tennessee, 38117, United States of America.
Over the last 9 years, insiders at Wright Medical NV have traded over $526,674,381 worth of Wright Medical NV stock and bought 118,654 units worth $2,654,459 . The most active insiders traders include Sean Carney, Elizabeth H Weatherman és Holdings Cooperatief U.A.Wa.... On average, Wright Medical NV executives and independent directors trade stock every 9 days with the average trade being worth of $4,402,563. The most recent stock trade was executed by Tim Lanier on 17 August 2020, trading 951 units of WMGI stock currently worth $28,644.
Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.
Wright Medical NV executives and other stock owners filed with the SEC include: